A clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases.

Sectors
Healthcare
Life Sciences
First Invested
2017
Public/PIPES
Company Status
IPO/Public
NASDAQ: VRNA
Associated Team
Lulu Xu
Paul Walker